SG11201913808SA - Pharmaceutical composition for preventing or treating osteoarthritis - Google Patents
Pharmaceutical composition for preventing or treating osteoarthritisInfo
- Publication number
- SG11201913808SA SG11201913808SA SG11201913808SA SG11201913808SA SG11201913808SA SG 11201913808S A SG11201913808S A SG 11201913808SA SG 11201913808S A SG11201913808S A SG 11201913808SA SG 11201913808S A SG11201913808S A SG 11201913808SA SG 11201913808S A SG11201913808S A SG 11201913808SA
- Authority
- SG
- Singapore
- Prior art keywords
- preventing
- pharmaceutical composition
- treating osteoarthritis
- osteoarthritis
- treating
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/32—Bones; Osteocytes; Osteoblasts; Tendons; Tenocytes; Teeth; Odontoblasts; Cartilage; Chondrocytes; Synovial membrane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/1841—Transforming growth factor [TGF]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
- C12N5/0655—Chondrocytes; Cartilage
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/15—Transforming growth factor beta (TGF-β)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2529/00—Culture process characterised by the use of electromagnetic stimulation
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0697—Artificial constructs associating cells of different lineages, e.g. tissue equivalents
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR20170083560 | 2017-06-30 | ||
| PCT/KR2018/007437 WO2019004794A1 (en) | 2017-06-30 | 2018-06-29 | Pharmaceutical composition for preventing or treating osteoarthritis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201913808SA true SG11201913808SA (en) | 2020-01-30 |
Family
ID=64742594
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201913808SA SG11201913808SA (en) | 2017-06-30 | 2018-06-29 | Pharmaceutical composition for preventing or treating osteoarthritis |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20200121726A1 (en) |
| EP (1) | EP3646878A4 (en) |
| JP (1) | JP7452925B2 (en) |
| KR (2) | KR20190003413A (en) |
| CN (1) | CN111050781A (en) |
| AU (2) | AU2018290628B2 (en) |
| CA (1) | CA3068550A1 (en) |
| SG (1) | SG11201913808SA (en) |
| WO (1) | WO2019004794A1 (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102275313B1 (en) * | 2019-02-12 | 2021-07-09 | 전남대학교산학협력단 | Composition for preventing and treating arthritis comprising a DEC1 expression and activity modulator |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6413511B1 (en) * | 1990-12-20 | 2002-07-02 | University Of Pittsburgh Of The Commonwealth System Of Higher Education | Cartilage alterations by administering to joints chondrocytes comprising a heterologous polynucleotide |
| US7431922B2 (en) * | 2002-03-29 | 2008-10-07 | Tissuegene, Inc. | Bioadhesive directed somatic cell therapy |
| US7005127B2 (en) * | 2002-03-29 | 2006-02-28 | Tissuegene, Inc. | Mixed-cell gene therapy |
| ES2396689T3 (en) | 2003-12-11 | 2013-02-25 | Isto Technologies Inc. | Particle Cartilage System |
| WO2006060723A2 (en) * | 2004-12-03 | 2006-06-08 | Vical Incorporated | Methods for producing block copolymer/amphiphilic particles |
| EP2268312A4 (en) * | 2008-03-21 | 2012-09-05 | Tissuegene Inc | Treatment of intervertebral disc degeneration |
| KR20110074773A (en) * | 2008-10-24 | 2011-07-01 | 가부시키가이샤 구라레 | Cell culture kit, screening method, and cell culture kit manufacturing method |
| KR101649375B1 (en) * | 2009-09-23 | 2016-08-30 | 건국대학교 산학협력단 | The method of manufacturing the transplantable spheroids of mixed cellular complexes for cell transplantation and the usage of the same |
| EP2981606B1 (en) | 2013-04-05 | 2020-09-02 | University Health Network | Methods and compositions for generating chondrocyte lineage cells and/or cartilage like tissue |
| WO2014192909A1 (en) * | 2013-05-31 | 2014-12-04 | ｉＨｅａｒｔ Ｊａｐａｎ株式会社 | Layered cell sheet incorporating hydrogel |
| KR20150014369A (en) | 2013-07-24 | 2015-02-06 | 주식회사 엠씨티티바이오 | Method for preparation of bead-type chondrocyte therapeutic agent |
| JP6475847B2 (en) * | 2015-02-06 | 2019-02-27 | コーロン ライフ サイエンス インコーポレイテッドＫｏｌｏｎ Ｌｉｆｅ Ｓｃｉｅｎｃｅ， Ｉｎｃ． | Composition for treating inflammatory disease induced by hyperimmune reaction |
| DK3368571T3 (en) * | 2015-10-30 | 2023-01-23 | Univ California | Transforming growth factor-beta responsive polypeptides and methods of use thereof |
-
2018
- 2018-06-29 JP JP2020522653A patent/JP7452925B2/en active Active
- 2018-06-29 CN CN201880055969.5A patent/CN111050781A/en active Pending
- 2018-06-29 WO PCT/KR2018/007437 patent/WO2019004794A1/en active Application Filing
- 2018-06-29 US US16/627,528 patent/US20200121726A1/en active Pending
- 2018-06-29 AU AU2018290628A patent/AU2018290628B2/en active Active
- 2018-06-29 KR KR1020180075947A patent/KR20190003413A/en active Application Filing
- 2018-06-29 EP EP18824811.6A patent/EP3646878A4/en active Pending
- 2018-06-29 CA CA3068550A patent/CA3068550A1/en active Pending
- 2018-06-29 SG SG11201913808SA patent/SG11201913808SA/en unknown
-
2020
- 2020-12-03 KR KR1020200167816A patent/KR102518314B1/en active IP Right Grant
-
2022
- 2022-03-01 AU AU2022201407A patent/AU2022201407A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| AU2022201407A1 (en) | 2022-03-24 |
| KR20200138143A (en) | 2020-12-09 |
| AU2018290628A1 (en) | 2020-02-20 |
| AU2018290628B2 (en) | 2022-03-17 |
| WO2019004794A1 (en) | 2019-01-03 |
| KR20190003413A (en) | 2019-01-09 |
| EP3646878A4 (en) | 2021-03-24 |
| CA3068550A1 (en) | 2019-01-03 |
| EP3646878A1 (en) | 2020-05-06 |
| KR102518314B1 (en) | 2023-04-05 |
| US20200121726A1 (en) | 2020-04-23 |
| JP7452925B2 (en) | 2024-03-19 |
| CN111050781A (en) | 2020-04-21 |
| JP2020525550A (en) | 2020-08-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL3616720T3 (en) | Pharmaceutical composition for cancer treatment | |
| IL271986B1 (en) | Pharmaceutical composition | |
| GB201712159D0 (en) | Pharmaceutical composition | |
| IL268416A (en) | Pharmaceutical combinations for treating cancer | |
| HK1244213A1 (en) | Pharmaceutical composition for preventing or treating fatty liver | |
| PL3129378T3 (en) | Bromodomain-inhibiting compounds and pharmaceutical composition comprising same for preventing or treating a cancer | |
| ZA201803320B (en) | Pharmaceutical compositions for treating pain | |
| EP3329929A4 (en) | Pharmaceutical composition for preventing or treating dry eyes | |
| GB201719447D0 (en) | Pharmaceutical composition | |
| IL272419A (en) | Pharmaceutical composition | |
| HK1232128A1 (en) | Pharmaceutical composition for preventing or treating skin rash | |
| HK1250627A1 (en) | Solid pharmaceutical compositions for treating hcv | |
| HK1248130A1 (en) | Composition for treating pain | |
| IL275525A (en) | Pharmaceutical composition for the treatment of cancer | |
| PL3290051T3 (en) | Pharmaceutical composition for treating and/or preventing cancer | |
| EP3727485C0 (en) | Pharmaceutical composition | |
| HK1255203A1 (en) | Solid pharmaceutical compositions for treating hcv | |
| SG11201913808SA (en) | Pharmaceutical composition for preventing or treating osteoarthritis | |
| EP3372233A4 (en) | Pharmaceutical composition for treating and/or preventing cancer | |
| HUE051563T2 (en) | Pharmaceutical composition for preventing or treating cancer | |
| IL267059A (en) | Composition for the treatment of osteoarthritis | |
| GB201714241D0 (en) | Pharmaceutical compositions for the treatment of proteinopathies | |
| GB201708328D0 (en) | Pharmaceutical composition | |
| GB201708329D0 (en) | Pharmaceutical composition | |
| GB201705661D0 (en) | Pharmaceutical composition |